drug

Magnetic Seizure Therapy (MST)

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
DEVICE
Pre-approval / investigational in the US
Developed by Centre for Addiction and Mental Health
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
DEVICE

Indications

Trials

1
Magnetic Seizure Therapy for Schizophrenia - Trial
NCT06672588—Recruiting

KOLs & investigators

1
Daniel H. Mathalon, Ph.D., M.D.KOL score 5

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Centre for Addiction and Mental Health
company
trial
Magnetic Seizure Therapy for Schizophrenia - Trial
NA
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Schizophrenia, Treatment-Resistant
indication
Treatment Resistant Schizophrenia
indication
KOL
Daniel H. Mathalon, Ph.D., M.D.
KOL score 5
person